RT Journal Article
SR Electronic
T1 Effect of underlying comorbidities on the infection and severity of COVID-19 in South Korea
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.08.20095174
DO 10.1101/2020.05.08.20095174
A1 Ji, Wonjun
A1 Huh, Kyungmin
A1 Kang, Minsun
A1 Hong, Jinwook
A1 Bae, Gi Hwan
A1 Lee, Rugyeom
A1 Na, Yewon
A1 Choi, Hyoseon
A1 Gong, Seon Yeong
A1 Choi, Yoon-Hyeong
A1 Ko, Kwang-Pil
A1 Im, Jeong-Soo
A1 Jung, Jaehun
YR 2020
UL http://medrxiv.org/content/early/2020/05/11/2020.05.08.20095174.abstract
AB Background The coronavirus disease (COVID-19) pandemic is an emerging threat worldwide. It is still unclear how comorbidities affect the risk of infection and severity of COVID-19.Methods A nationwide retrospective case-control study of 65,149 individuals, aged 18 years or older, whose medical cost for COVID-19 testing were claimed until April 8, 2020. The diagnosis of COVID-19 and severity of COVID-19 infection were identified from the reimbursement data using diagnosis codes and based on whether respiratory support was used, respectively. Odds ratios were estimated using multiple logistic regression, after adjusting for age, sex, region, healthcare utilization, and insurance status.Results The COVID-19 group (5,172 of 65,149) was younger and showed higher proportion of females. 5.6% (293 of 5,172) of COVID-19 cases were severe. The severe COVID-19 group had older patients and a higher male ratio than the non-severe group. Cushing syndrome (Odds ratio range (ORR) 2.059-2.358), chronic renal disease (ORR 1.292-1.604), anemia (OR 1.132), bone marrow dysfunction (ORR 1.471-1.645), and schizophrenia (ORR 1.287-1.556) showed significant association with infection of COVID-19. In terms of severity, diabetes (OR 1.417, 95% CI 1.047-1.917), hypertension (OR 1.378, 95% CI 1.008-1.883), heart failure (ORR 1.562-1.730), chronic lower respiratory disease (ORR 1.361-1.413), non-infectious lower digestive system disease (ORR 1.361-1.418), rheumatoid arthritis (ORR 1.865-1.908), substance use (ORR 2.790-2.848), and schizophrenia (ORR 3.434-3.833) were related with severe COVID-19.Conclusions We identified several comorbidities associated with COVID-19. Health care workers should be more careful when diagnosing and treating COVID-19 when the patient has the above-mentioned comorbidities.Take Home message Comorbidities that might be associated with COVID-19 infection and severe clinical course were identified, which could assist in formulating public health measures to mitigate the risk in groups with increased risk.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from the Gachon University Gil Medical Center (grant nos. 2018-17 and 2019-11). The sponsor of the study was not involved in the study design, analysis, and interpretation of data; writing of the report; or the decision to submit the study results for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesYou can check the data on the site below. https://hira-covid19.net/ https://hira-covid19.net/